<div id="readability-page-1"><p>MBL Wealth LLC acquired a new position in shares of  HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,891 shares of the company's stock, valued at approximately $1,232,000.</p><ul><li>MarketBeat Week in Review – 07/28 - 08/01</li></ul><p>A number of other hedge funds have also recently made changes to their positions in HCA. HBK Sorce Advisory LLC bought a new position in  HCA Healthcare during the 3rd quarter valued at approximately $540,000.  Compound Global Advisors LLC purchased a new position in shares of  HCA Healthcare in the 3rd quarter worth about $44,000.  CWM LLC grew its position in  HCA Healthcare by 14.6% during the 3rd quarter. CWM LLC now owns 14,975 shares of the company's stock valued at $6,382,000 after purchasing an additional 1,913 shares during the last quarter.  Pacer Advisors Inc. increased its stake in  HCA Healthcare by 6,115.3% during the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company's stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter.  Finally, Harbor Capital Advisors Inc. grew its holdings in shares of  HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company's stock valued at $32,000 after buying an additional 34 shares during the last quarter. 62.73% of the stock is owned by institutional investors. </p><div><p><span></span><span>Get <strong>HCA Healthcare</strong> alerts:</span></p></div><h2>Insiders Place Their Bets</h2><p>In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. This represents a 52.74% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own  1.30% of the company's stock. </p><h2>HCA Healthcare Trading Up 0.0%</h2><ul><li>Can HCA Healthcare Revive the Market’s Weakest Sector?</li></ul><p>Shares of HCA stock opened at $474.06 on Friday. The company has a 50 day simple moving average of $474.62 and a two-hundred day simple moving average of $419.32. The stock has a market cap of $108.18 billion, a P/E ratio of 18.32, a P/E/G ratio of 1.40 and a beta of 1.36. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $520.00. </p><p>HCA Healthcare (NYSE:HCA - Get Free Report) last posted its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.HCA Healthcare's revenue was up 9.6% on a year-over-year basis. During the same period in the prior year, the business posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS.  As a group, equities analysts forecast that  HCA Healthcare, Inc. will post 24.98 earnings per share for the current year. </p><h2>HCA Healthcare Dividend Announcement</h2><ul><li>Can Integrated Healthcare Stocks Succeed in Public Markets?</li></ul><p>The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare's payout ratio is 11.13%. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several research firms recently issued reports on HCA. Oppenheimer upped their price objective on HCA Healthcare from $400.00 to $500.00 and gave the company an &#34;outperform&#34; rating in a research report on Monday, October 27th. Jefferies Financial Group increased their price objective on HCA Healthcare from $485.00 to $525.00 and gave the company a &#34;buy&#34; rating in a research report on Tuesday, October 28th. Raymond James Financial  set a $525.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Sanford C. Bernstein  reissued a &#34;market perform&#34; rating and set a $417.00 price objective on shares of HCA Healthcare in a report on Monday, October 27th. Finally, UBS Group lifted their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a &#34;buy&#34; rating in a research report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one  has given a Sell rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $479.00.</p><p><b>Read Our Latest Research Report on HCA Healthcare</b></p><h2>HCA Healthcare Profile</h2> (Free Report)<p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.  </p><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than HCA Healthcare</li><li>Do you know what Amazon is planning for January 1?</li><li>$100 Trillion “AI Metal” Found in American Ghost Town</li><li>Washington prepares for war</li><li>Put $1,000 into this stock by Jan 1 [Not NVDA]</li><li>Turn your &#34;dead money&#34; into $306+ monthly (starting this month)</li></ul><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2><p>Before you consider HCA Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>MBL Wealth LLC acquired 2,891 shares of HCA Healthcare, valued at approximately $1.23 million, during the 3rd quarter, as per their latest SEC filing. Other hedge funds also adjusted their positions in HCA. HCA's stock opened at $474.06, with a market cap of $108.18 billion. The company reported strong quarterly earnings, with a revenue increase of 9.6% year-over-year. Analysts have issued positive growth forecasts for HCA, with several raising their price targets.</p>

MBL Wealth LLC Takes $1.23 Million Position in HCA Healthcare, Inc. $HCA